TICKERNERD
Menu
WALDWALDConsumer Defensive · Household & Personal Products

WALD Stock Forecast: Waldencast plc Price Predictions for 2026-2027

Last close, 2 Oct 2026
$0.88
−4.77% on the day

The 2 Wall Street analysts covering Waldencast plc hold a median 12-month price target of $2.05 — +133.2% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 61 of 100 as at 3 Oct 2026 — in the upper half.

Market cap
$108.1M
Ticker Nerd rank
61/ 100
Median analyst target
$2.05
Analysts covering
2
Total return, dividends reinvested
1W
−14.7%
1M
−34.9%
YTD
−53.2%
1Y
−53.0%
From 52W high
−71.5%
From 52W low
+15.2%
$0.76
$3.08
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

WALD stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Waldencast plc on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 3 Oct 2026
61/ 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Accruals
96
Size
74
Issuance
72
Volatility
70
Value
67
Quality
65
Growth
46
Revisions
26
Momentum
14

Accruals (96): Reported profit is backed by cash, and the company is not expanding recklessly.

Momentum (14): The shares have been drifting down relative to others.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

WALD stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on WALD, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$1.00$1.50$2.00$2.50Jan 26Apr 26Jul 26Oct 26WALDHigh $2.50Median $2.05Low $1.60

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says2 analysts
1 Buy1 Hold0 Sell
Low $1.60Median $2.05High $2.50

The green dot is the last close — the median target sits +133.2% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
2 June 2026Canaccord GenuityMaintainsBuy$2.00 → $3.00
16 Mar 2026Canaccord GenuityMaintainsBuy—
16 Mar 2026Telsey Advisory GroupMaintainsMarket Perform—
14 Jan 2026JefferiesAssumesBuy$2.00
25 Nov 2025Canaccord GenuityMaintainsBuy—
25 Nov 2025Telsey Advisory GroupDowngradeMarket Perform—
20 Aug 2025Telsey Advisory GroupMaintainsOutperform—
13 Aug 2025Telsey Advisory GroupMaintainsOutperform—
15 May 2025Canaccord GenuityMaintainsBuy—
15 May 2025Telsey Advisory GroupMaintainsOutperform—
6 May 2025Telsey Advisory GroupMaintainsOutperform—
22 Apr 2025Alliance Global PartnersInitiatesBuy—
20 Mar 2025Telsey Advisory GroupMaintainsOutperform—
19 Mar 2025DA DavidsonMaintainsBuy—
19 Mar 2025Telsey Advisory GroupMaintainsOutperform—
11 Mar 2025Telsey Advisory GroupMaintainsOutperform—
16 Dec 2024TD CowenInitiatesHold—
4 Dec 2024DA DavidsonMaintainsBuy—
22 Nov 2024Canaccord GenuityMaintainsBuy—
22 Nov 2024Telsey Advisory GroupMaintainsOutperform—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

WALD appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,600 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track, part by part, and one part in full with each verdict.
  • The AI build-out, every Wednesday: how AI stocks did, part by part.

Free. Unsubscribe any time.

Performance

WALD vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 2 Oct 2026, Waldencast plc returned −53.0% against +16.2% for the S&P 500, dividends included.

WALD vs S&P 500, last 12 monthsTotal return, rebased to 100
406080100120140Jan 26Apr 26Jul 26Oct 26WALDS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

WALD analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
Analysts raising
1
Analysts cutting
2
Fundamentals

Waldencast plc (WALD) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
—
Price / sales
0.5×

Cheaper than 82% of US stocks

Price / book
0.3×

Cheaper than 87% of US stocks

EV / EBITDA
−9.3×

Cheaper than 85% of US stocks

Growth & margins
Revenue growth (YoY)
−80.3%

Higher than 3% of US stocks

Earnings growth (YoY)
—
Gross margin
—
Operating margin
−156.9%

Higher than 12% of US stocks

Net margin
−70.2%

Higher than 8% of US stocks

Returns & dividend
Return on equity
−62.7%

Higher than 19% of US stocks

Return on assets
−7.5%

Higher than 29% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Waldencast plc (WALD) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Waldencast plc has a market value of $108.1M and an enterprise value of $254.9M.

  • Shares outstanding: 128.2M.

  • forward P/E: −1.1× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Waldencast plc employs 367 people.

market figures as at 21 Oct 2026

Data provided by Twelve Data

Peers

WALD vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelHousehold & Personal Products
CompanyMarket capTKN rank
WALDWaldencast plc$108.1M61
SKINSkinhealth Systems, Inc.$72.2M80
SLSNSolesence, Inc.$60.5M34
NUSNu Skin Enterprises, Inc.$241.9M65
ACUAcme United Corp.$246.0M99
GROVGrove Collaborative Holdings, Inc.$42.4M87
MAGNMagnera Corp.$421.5M73

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Waldencast plc — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest WALD news & analysis

Waldencast plc Files Form 15 to Deregister its Securities and Suspend its SEC Reporting Obligations under the Exchange Act

GlobeNewsWire · 15 Oct 2026neutral

Waldencast filed Form 15 with the SEC on October 15, 2026, to terminate registration of its Class A ordinary shares and warrants under the Exchange Act. The filing immediately suspended the company’s obligation to submit periodic and current SEC reports.

Why it matters — WALD watchers may note the company will no longer be required to file periodic and current reports with the SEC while the suspension is in effect.

Waldencast plc Announces First Half 2026 Financial Results

GlobeNewsWire · 28 Sept 2026neutral

Waldencast plc, parent company of Milk Makeup, announced its operating results for the six months ended June 30, 2026 (H1 2026) on September 28, 2026, and provided a business update. The announcement was made from New York via GlobeNewsWire.

Why it matters — WALD watchers would care because the announcement provides the company's latest half-year financial performance and an update on its business operations.

Waldencast plc Files Form 25 to Voluntary Delist from Nasdaq and Deregister its Securities under the Exchange Act

GlobeNewsWire · 24 Sept 2026negative

Waldencast plc has filed a Form 25 with the SEC to voluntarily delist its Class A ordinary shares and redeemable warrants from Nasdaq and deregister them under the Exchange Act. The company expects the last trading day on Nasdaq to be on or about October 2, 2026.

Why it matters — A WALD watcher would care because the voluntary delisting and deregistration will remove the company's securities from public trading on Nasdaq and end its SEC reporting obligations.

Waldencast plc Announces Intention to Voluntarily Delist from Nasdaq and Deregister its Securities under the Exchange Act

GlobeNewsWire · 14 Sept 2026neutral

Waldencast plc's Board has approved the voluntary delisting of its Class A Ordinary Shares and Warrants from Nasdaq, along with the deregistration of those securities under the Exchange Act. The company expects to file a Form 25 with the SEC on or about September 24, 2026, with delisting expected to become effective on or about October 4, 2026, and the last day of trading on Nasdaq expected to be October 2, 2026. The Board also plans to recommend that shareholders approve renaming the company Milk Makeup plc.

Why it matters — A WALD watcher would care because the planned delisting and deregistration mark a significant structural change in how the company's securities will trade and be regulated, alongside a proposed corporate renaming.

Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepoint

GlobeNewsWire · 30 July 2026positive

Waldencast plc announced it has completed the sale of its Obagi Medical dermatological skincare business to Bridgepoint in a transaction valued at up to $460 million, subject to customary adjustments.

Why it matters — The sale represents a major step in Waldencast's strategy to strengthen its balance sheet and focus resources on accelerating the global growth of its remaining brand, Milk Makeup.

FAQ

Frequently asked questions about WALD stock

What is the WALD stock price forecast for 2026-2027?

The 2 Wall Street analysts covering Waldencast plc have a median 12-month price target of $2.05, with estimates ranging from $1.6 to $2.5. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is WALD stock a buy right now?

Of the 2 analysts covering Waldencast plc, 1 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Waldencast plc 61 out of 100 across roughly 4,600 US stocks as at 3 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank WALD?

As at 3 Oct 2026, Waldencast plc ranks 61 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Accruals (96 of 100).

Will WALD stock go up?

No one can know that. What the data says: the median 12-month target from 2 analysts implies +133.2% from the last close, and Ticker Nerd's factor model ranks Waldencast plc 61 out of 100 as at 3 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the WALD stock forecast for 2030?

No analyst covering Waldencast plc publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for WALD are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $1.6 to $2.5 over the next 12 months.

How has WALD stock performed over the past year?

Waldencast plc returned -53.0% over the 12 months to 2 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Waldencast plc do?

Waldencast plc is a global beauty and wellness company that develops, acquires, and operates consumer-focused brands across skincare, cosmetics, and related personal-care categories. Its portfolio includes Obagi Medical, which offers science-led skincare products designed to address concerns such as hyperpigmentation, visible signs of aging, fine lines, wrinkles, and skin tone and texture, alongside medical-grade aesthetic solutions and injectable hyaluronic acid products.

What is the latest news on WALD?

The most recent item we track (GlobeNewsWire, 15 Oct 2026): "Waldencast plc Files Form 15 to Deregister its Securities and Suspend its SEC Reporting Obligations under the Exchange Act". Waldencast filed Form 15 with the SEC on October 15, 2026, to terminate registration of its Class A ordinary shares and warrants under the Exchange Act. The filing immediately suspended the company’s obligation to submit periodic and current SEC reports.

Company

About Waldencast plc.

Waldencast plc is a global beauty and wellness company that develops, acquires, and operates consumer-focused brands across skincare, cosmetics, and related personal-care categories. Its portfolio includes Obagi Medical, which offers science-led skincare products designed to address concerns such as hyperpigmentation, visible signs of aging, fine lines, wrinkles, and skin tone and texture, alongside medical-grade aesthetic solutions and injectable hyaluronic acid products. The company also operates Milk Makeup, a clean prestige beauty brand offering color cosmetics, skincare, and other beauty products shaped by contemporary creative culture. Waldencast serves consumers through retail, digital commerce, professional skincare channels, and other distribution partners across North America, Europe, the Middle East, India, Australia, and New Zealand. By combining clinically oriented skincare with expressive makeup and wellness-related beauty offerings, Waldencast plc occupies a diversified position within the global beauty and personal-care market, connecting professional-use products with accessible consumer brands.

CEO Mr. Felipe Dutra · 367 employees · United Kingdom · https://www.waldencast.com